Improving access to antipsychotic medications for schizophrenia in Ethiopia, Nigeria, Rwanda, and South Africa: an evidence-based global consensus

The Lancet Psychiatry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles